Non CYP Mediated Metabolism Pathways and In Vitro Evaluation Strategies
Discover non-CYP metabolism pathways, key enzymes, and in vitro strategies for safer drug development in this webinar.
Building New Approach Methodologies (NAMs) and Complex In Vitro Assays
Learn how Lonza’s primary human cells, media, and reagents support advanced in vitro models for drug discovery, toxicity testing, and reducing animal use.
Enhance Your Tissue Processing Efficiency with the STEMprep™ Tissue Dissociator
Join Drs. Amanda Durkin and Grace Poon on October 2 as they explore how the STEMprep™ Tissue Dissociator System can simplify tissue processing and boost the efficiency of your biological research.
Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration
As the FDA and NIH encourage a shift away from animal testing, there’s growing momentum behind New Approach Methodologies (NAMs) — from advanced in vitro models to computational platforms. In this webinar, Concept Life Sciences and Delta4 present a powerful example of what this future looks like in practice.
Exploring the iPSC-Derived Neuronal-Glia Co-culture System: A Powerful Drug Discovery Platform for Studying Neurodegenerative Diseases
Learn how FUJIFILM’s iPSC-derived neuron-glia co-culture system supports drug discovery and disease modeling for neurodegenerative disorders.
Reprogramming Mouse Fibroblasts Into Induced Cardiomyocytes: Age-Related, Metabolic, and Epigenetic Barriers
Join Dr. Sandrina Nóbrega-Pereira as she discusses the role of age, epigenetics, and mitochondrial metabolism in the Direct Cardiac Conversion (DCC) of fibroblasts into induced cardiomyocytes (iCMs).
Vaccine-Boosting CAR T Cells Against Solid Tumors
Learn how a novel amphiphilic ligand boosts CAR T cells in vivo, enhances tumor targeting, and activates endogenous immunity—offering a promising new strategy for treating solid tumors.
Novel Applications of the Cellular Thermal Shift Assay (CETSA) Provide New Insights for Drug Discovery
Join AbbVie scientists Shitalben Patel and Jami R. Erickson as they showcase their innovative advancements, transforming CETSA® into a high-throughput flow-based platform and introducing new whole blood formats to elevate drug discovery.
Redox Regulation of Skeletal Muscle: A Journey from Liverpool to the International Space Station
Dr. Anne McArdle and Dr. Malcolm Jackson explore groundbreaking research from the Muscle Laboratories at the University of Liverpool. They examine how redox regulation influences the adaptive responses of skeletal muscle during physical activity and how these processes evolve with age.
Launch Event: Propelling Boundaries – Innovative Technologies in Early Drug Discovery
Join WuXi Biology Early Discovery Platform's experts as they discuss the innovative and latest technology updates in small and new molecule drug discovery.
Advances in Preclinical Research using Human Co-culture Models: Applications in Immunology, Infectious Disease, and Oncology
Join Dr. Ethan Shelkey as he discusses human primary co-culture models with immune cells that are used in infectious disease studies and cancer therapeutic testing.
Integrating Regulatory Guidance and Sustainable Skin Procurement for Consistent Execution of In Vitro Permeation Testing
Join LifeNet Health LifeSciences for our first Assay Services webinar, focusing on Dermal Absorption. This session explores in vitro permeation testing, a crucial method for assessing a compound’s potential to penetrate the skin and reach systemic circulation.
Cell-Based Assays for Immuno-oncology
Join Lonza scientist Ethan Shelkey as he explores how cell-based assays can assess immune activation and support immunotherapy development.
Artificial Intelligence in Preclinical Research: Pathology, Biospecimens, and Model Selection
Learn how AI is advancing preclinical research through quantitative pathology, curated biospecimen data, and intelligent tumor model selection in this expert-led webinar.
CAR Finder – A Platform for Rapid CAR T Cell Screening
Dr. Sandy Tretbar introduces CAR Finder Technology and shares practical strategies to improve mRNA-based CAR T cell screening and selection.
CRISPR Gene Editing in Primary T Cells: A Case Study in the Fight Against HIV
Get practical insight into CRISPR-Cas9 gene editing in primary immune cells and how it can be applied to study drug action in a physiologically relevant model.
RIP1 Inhibition Protects Retinal Ganglion Cells in Preclinical Glaucoma Models
In this webinar, Bo Kyoung Kim, PhD discusses RIP1 kinase's role in glaucoma and its potential as a therapeutic target to preserve vision.
Fresh or Cryopreserved Leukopaks? Assessing the Impact of Different Storage Conditions on Leukopak Stability
Join Dr. Wassim Basheer from Charles River Laboratories as he shares impactful data looking at stability of fresh and cryopreserved leukopaks.
The Hidden Variable in Your Intestinal Organoids: Enhancing Differentiation for a More Predictive Model
Are you confident that your intestinal organoid models contain the right cell types to generate predictive, reproducible, and translatable results?
Biomarkers from Bench to Bedside: Tools, Targets, and Translational Insights
Explore how new tools and strategies are advancing biomarker discovery, standardization, and translational research in oncology and beyond.
Sustainable Science: Transforming Pharma-Supplier Partnerships
Join us to learn more about the importance of laboratory sustainability, how the industry can work together to create a culture of sustainability in science and ways sustainability can support the growth of your business.
Improved Clearance Predictions for Aldehyde Oxidase Substrates Using TruVivo, a Novel Human Hepatocyte Model
In this exclusive session, Stephanie Piekos, PhD, Senior Scientist at Boehringer Ingelheim, shares insights into the challenges of evaluating AO substrates and how more predictive, human-relevant models are shaping the future of DMPK studies.
Introduction to Bispecific Antibodies and Their Production
In this webinar, Dr. Brady Wu discusses bispecific antibody drugs and their production.
Integrating Functionalized Multi-omics in Oncology Drug Discovery
Discover how cutting-edge multi-omics approaches and Generative AI are reshaping oncology drug discovery.
Leveraging Genomic, Preclinical, and Drug Response Data in the Age of AI
Join Dr. Michael Boice from Certis Oncology for a discussion and demonstration of how artificial intelligence can improve preclinical decision-making in cancer research.
